SYSTEMS AND METHODS FOR OPTIMIZING VENTRICULAR PACING DELAYS DURING ATRIAL FIBRILLATION

• US 20110022106A1
• Filed: 07/22/2009
• Published: 01/27/2011
• Est. Priority Date: 07/22/2009
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Inventors: Min, Xiaoyi
• Granted Patent: US 8,396,551 B2
• Time in Patent Office: Days
• US Class Current: 607/14
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence
• CPC Class Codes: A61N 1/36842 Multi-site stimulation in the same chamber
• CPC Class Codes: A61N 1/36843 Bi-ventricular stimulation

Abstract

Techniques are provided for use by implantable medical devices for controlling ventricular pacing, particularly during atrial fibrillation. In one example, during a V sense test for use in optimizing ventricular pacing, the implantable device determines relative degrees of variation within antecedent and succedent intervals detected between ventricular events sensed on left ventricular (LV) and right ventricular (RV) sensing channels. Preferred or optimal ventricular pacing delays are then determined, in part, based on a comparison of the relative degrees of variation obtained during the V sense test. In another example, during RV and LV pace tests, the device distinguishes QRS complexes arising due to interventricular conduction from QRS complexes arising due to atrioventricular conduction from the atria, so as to permit the determination of correct paced interventricular conduction delays for the patient. The paced interventricular conduction delays are also used to optimize ventricular pacing. Biventricular and monoventricular pacing regimes are provided.

Claims

1. A method for controlling the delivery of cardiac pacing therapy by an implantable cardiac rhythm management device for use with patients subject to atrial fibrillation, the method comprising:

detecting atrial fibrillation (AF) within the patient, and in response to detecting AF performing the following;

determining a first degree of variation within intervals between ventricular events sensed by the device on a first channel and preceding ventricular events sensed on a second channel;

determining a second degree of variation within intervals between ventricular events sensed by the device on the first channel and subsequent ventricular events sensed on the second channel; and

controlling ventricular pacing based, at least in part, on a comparison of the first and second degrees of variation.

2. The method of claim 1 wherein the first sensing channel is a right ventricular (RV) sensing channel and the second sensing channel is a left ventricular (LV) sensing channel.

3. The method of claim 2 wherein the ventricular events sensed on the first channel are right ventricular depolarization (RV QRS) events and the ventricular events sensed on the second channel are left ventricular depolarization (LV QRS) events.

4. The method of claim 1 wherein determining the first degree of variation includes:

detecting a first set of intervals (Δ

−

) between the ventricular events sensed on the first channel and the preceding ventricular events sensed on the second channel; and

determining a degree of variation within the first set of intervals (Δ

−

).

5. The method of claim 4 wherein determining the second degree of variation includes:

detecting a second set of intervals (Δ

+) between the ventricular events sensed on the first channel and the preceding ventricular events sensed on the second channel; and

determining a degree of variation within the second set of intervals (Δ

+).

6. The method of claim 5 wherein controlling ventricular pacing includes:

determining an interventricular pacing delay (VV) based, at least in part, on a comparison of the relative degrees of variation in the first and second sets of intervals (Δ

−

,Δ

+); and

controlling biventricular pacing based on the interventricular pacing delay (VV).

7. The method of claim 6 wherein determining the interventricular pacing delay (VV) based on the comparison of the sets of intervals includes:

comparing the degree of variation in the Δ

−

intervals to the degree of variation in the Δ

+ intervals to determine which has a smaller degree of variation;

deriving an intrinsic interventricular delay (Δ

) for the patient based on the set of intervals having the smaller degree of variation; and

setting the interventricular pacing delay (VV) based, at least in part, on the intrinsic interventricular delay (Δ

).

8. The method of claim 7 wherein

if the degree of variation in the Δ

−

intervals is smaller than the degree of variation in the Δ

+ intervals, then the intrinsic interventricular delay (Δ

) is set equal to negative |Δ

−

|; and

if the degree of variation in the Δ

+ intervals is smaller than the degree of variation in the Δ

−

intervals, then the intrinsic interventricular delay (Δ

) is set equal to positive |Δ

+|.

9. The method of claim 7 further including:

determining a paced interventricular conduction delay from the RV to the LV of the patient (IVCD_RL);

determining a paced interventricular conduction delay from the LV to the RV of the patient (IVCD_LR);

determining an interventricular correction term (ε

) from IVCD_RL and IVCD_LR; and

setting the interventricular pacing delay (VV) for the patient based on the intrinsic interventricular delay (Δ

) and the interventricular correction term (ε

).

10. The method of claim 1 wherein determining the first degree of variation includes determining a standard deviation in intervals measured between the ventricular events of the first channel and the preceding ventricular events of the second channel.

11. The method of claim 1 wherein determining the second degree of variation includes determining a median of intervals measured between the ventricular events of the first channel and the preceding ventricular events of the second channel and evaluating a number of intervals occurring within a range surrounding the median subject to a predetermined confidence interval.

12. The method of claim 5 wherein controlling ventricular pacing includes:

comparing the degree of variation in the Δ

−

intervals to the degree of variation in the Δ

+ intervals to determine which has a smaller degree of variation;

if the degree of variation in the Δ

−

intervals is smaller than the degree of variation in the Δ

+ intervals, then upon detection of a sensed QRS in the LV, immediately delivering a monoventricular pacing pulse to the RV; and

if the degree of variation in the Δ

+ intervals is smaller than the degree of variation in the Δ

−

intervals, then upon detection of a sensed QRS in the RV, immediately delivering a monoventricular pacing pulse to the LV.

13. The method of claim 1 wherein all of the steps are performed by the implantable medical device.

14. A system for controlling the delivery of cardiac pacing therapy by an implantable cardiac rhythm management device for use with patients subject to atrial fibrillation (AF), the system comprising:

an AF detection unit operative to detect an episode of AF;

an interval variation determination unit operative in response to the detection of AF to determine a first degree of variation within intervals between ventricular events sensed on a first channel and preceding ventricular events sensed on a second channel;

the interval variation determination unit further operative to determine a second degree of variation between ventricular events sensed on the first channel and subsequent ventricular events sensed on the second channel; and

a ventricular pacing controller operative to control ventricular pacing based, at least in part, on a comparison of the first and second degrees of variation.

15. A system for controlling the delivery of cardiac pacing therapy by an implantable cardiac rhythm management device for use with patients subject to atrial fibrillation (AF), the system comprising:

means for detecting AF

means, responsive to a detection of AF, for determining a first degree of variation within intervals between ventricular events sensed by the device on a first channel and preceding ventricular events sensed on a second channel;

means for determining a second degree of variation within intervals between ventricular events sensed by the device on the first channel and subsequent ventricular events sensed on the second channel; and

means for controlling ventricular pacing based, at least in part, on a comparison of the first and second degrees of variation.